Actively Recruiting
The Effect of Intrawound Vancomycin Powder in Spine Surgery
Led by Windsor-Essex Compassionate Care Community · Updated on 2024-04-23
1643
Participants Needed
2
Research Sites
348 weeks
Total Duration
On this page
Sponsors
W
Windsor-Essex Compassionate Care Community
Lead Sponsor
C
Cairo University
Collaborating Sponsor
AI-Summary
What this Trial Is About
Problem: Postoperative wound infection following various spinal surgeries is a serious complication. The incidence of post-surgical wounds in spine surgery is high, and various researchers have reported different infection rates. In addition, increased healthcare costs, prolonged lengths of stay in hospital, and reduced quality of life as a result of surgical site infections (SSI) are also major concerns. Several methods for avoiding SSI, such as betadine irrigation, vacuum-assisted closure, and intra-wound vancomycin powder, have been used to reduce the rate of wound infection in spine surgery. Use of local vancomycin has been popular because of its protective effects and lower cost. According to some reports, prophylactic administration of intra-wound vancomycin powder before wound closure is an effective method for decreasing postoperative wound infection rates; however, other studies have revealed a non-significant effect of intra-wound vancomycin use for decreasing the postsurgical wound infection rate. Solution: Therefore, the investigators will prospectively randomize all various types of spinal surgeries to patients who will receive intrawound vancomycin powder and control group who will not receive the powder and to see it's effect in reducing the post-surgical infection.
CONDITIONS
Official Title
The Effect of Intrawound Vancomycin Powder in Spine Surgery
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients requiring surgery due to any spine disease
- Patients aged 18 years or older
You will not qualify if you...
- History of infections at the spine surgical site
- Undergoing a biopsy procedure
- Postoperative follow-up time less than 12 weeks
- Allergy to vancomycin
- Age less than 18 years
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 2 locations
1
Windsor Regional Hospital - Ouellette
Windsor, Ontario, Canada, N9A 1E1
Actively Recruiting
2
Cairo University Hospitals
Cairo, Egypt, 11562
Actively Recruiting
Research Team
M
Mohamed Soliman, MSc, MD
CONTACT
A
Abdalla Shamisa, FRCSC
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
PREVENTION
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here